Chinese-made mRNA vaccine starts trial production

China’s CanSino Biologics Inc https://www.reuters.com/companies/6185.HK” target=”_blank” rel=”noopener”>(6185.HK) has entered “test production phase” for its COVID-19 mRNA booster vaccine, the company said in a post on its social media account late on Thursday.
Read More

What's Hot

Snap Health Acquires Leading Healthcare Service Provider Your Therapy Source

HIV treatment fell inexcusably behind due to COVID lockdown

Western Australia To Ban Anti-Gay Conversion Practices

Chinese-made mRNA vaccine starts trial production | Reuters

Corporations try to kill Oklahoma rule that aims to keep medicine by mail from getting too hot or too cold

Peptide 3D-printing inks could advance regenerative medicine

3 Potential Consequences of Ending the COVID Public Health Emergency Status

How Yo X Scaled Through COVID-19 Pandemic To Becoming A Hit Maker

Snap Health Acquires Leading Healthcare Service Provider Your Therapy Source

HIV treatment fell inexcusably behind due to COVID lockdown

Western Australia To Ban Anti-Gay Conversion Practices

Martha Eddy Jentz has been Inducted into the Prestigious Marquis Who’s Who Biographical Registry

Bruce Springsteen and These Lost Years

China’s long-term future with Covid-19 will depend on accurate data

The NIH-led research response to COVID-19 | Science

EdTech and Smart Classrooms Market Size Is Projected to Reach US$ 127.77 Bn and Grow at CAGR 13.56% over Forecasts Period 2023-2030 : Key Players: Apple Inc., Blackboard

China Reports 50% Decrease in COVID-Related Deaths

COVID-19: Saskatoon and Regina’s wastewater virus levels remain on the rise

What's Hot

Chinese-made mRNA vaccine starts trial production | Reuters

Related Posts